TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.

Kevin Kalinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.